Arbutus Biopharma Corporation (ABUS)

NASDAQ: ABUS · Real-Time Price · USD

4.620

-0.030 (-0.65%)

At close: Jan 9, 2026, 4:00 PM EST

4.790

+0.170 (3.68%)

After-hours: Jan 9, 2026, 6:57 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2003 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2003 - 2019
Novel Therapeutics	6.17M	Log In	Log In	Log In	Log In	Upgrade
Novel Therapeutics Growth	-65.98%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2003 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2003 - 2019
United States	6.17M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-65.98%	Log In	Log In	Log In	Log In	Upgrade